|
1
|
Breathnach OS, Freidlin B, Conley B, et
al: Twenty-two years of phase III trials for patients with advanced
non-small-cell lung cancer: sobering results. J Clin Oncol.
19:1734–1742. 2001.PubMed/NCBI
|
|
2
|
Quint LE, Tummala S, Brisson LJ, et al:
Distribution of distant metastases from newly diagnosed non-small
cell lung cancer. Ann Thorac Surg. 62:246–250. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Line DH and Deeley TJ: The necropsy
findings in carcinoma of the bronchus. Br J Dis Chest. 65:238–242.
1971. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakamura E, Shimizu M, Itoh T and Manabe
T: Secondary tumors of the pancreas: clinicopathological study of
103 autopsy cases of Japanese patients. Pathol Int. 51:686–690.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Adsay NV, Andea A, Basturk O, Kilinc N,
Nassar H and Cheng JD: Secondary tumors of the pancreas: an
analysis of asurgical and autopsydatabase and review of the
literature. Virchows Arch. 444:527–535. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Z'Graggen K, Fernández-del Castillo C,
Rattner DW, Sigala H and Warshaw AL: Metastases to thepancreas and
their surgical extirpation. Arch Surg. 133:413–417. discussion
418-4191998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: American Joint Committee on Cancer (AJCC)
Cancer Staging Manual. 7th. Springer, Inc.; Chicago, IL: 2010
|
|
8
|
Oken MM, Creech RH, Tormey DC, et al:
Toxicity and response criteria of the Eastern Cooperative Oncology
Group. Am J Clin Oncol. 5:649–655. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zerbi A and Pecorelli N: Pancreatic
metastases: An increasing clinical entity. World J Gastrointest
Surg. 2:255–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bestari MB and Agustanti N: Obstructive
jaundice due to pancreatic metastasis from non-small cell lung
cancer. Acta Med Indones. 45:216–219. 2013.PubMed/NCBI
|
|
11
|
Merkle EM, Boaz T, Kolokythas O, Haaga JR,
Lewin JS and Brambs HJ: Metastases to the pancreas. Br J Radiol.
71:1208–1214. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pericleous S, Mukherjee S and Hutchins RR:
Lung adenocarcinoma presenting as obstructive jaundice: a
casereport and review of literature. World J Surg Oncol. 6:1202008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu SF, Zhang S, Chen YC, et al:
Experience of cancer care for metastasis-induced acute pancreatitis
patients with lung cancer. J Thorac Oncol. 4:1231–1235. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schwarz RE, Chu PG and Grannis FW Jr:
Pancreatic tumors in patients with lung malignancies: a spectrum of
clinicopathologic considerations. South Med J. 97:811–815. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sato M, Okumura T, Kaito K, et al:
Usefulness of FDG-PET/CT in the detection of pancreatic metastases
from lung cancer. Ann Nucl Med. 23:49–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xi-wen S and Shu-zhen C: Characterization
of pancreatic metastases from primary lung cancer using magnetic
resonance imaging. Clin Imaging. 34:351–354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Onuigbo WI: Lung cancer metastasis to
thepancreas and its surrounding lymph nodes. Br J Dis Chest.
60:152–155. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harlamert HA, Mira J, Bejarano PA, et al:
Thyroid transcription factor-1 and cytokeratins 7 and 20
inpulmonary and breast carcinoma. Acta Cytol. 42:1382–1388. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mori N, Sawada T, Satoh H, Kawaguchi M,
Hara H and Matsushita K: A resected case of solitary pancreatic
metastasis from adenocarcinoma of the lung. JOP. 9:698–703.
2008.PubMed/NCBI
|
|
20
|
Maeno T, Satoh H, Ishikawa H, et al:
Patterns of pancreatic metastasis from lung cancer. Anticancer Res.
18:2881–2884. 1998.PubMed/NCBI
|
|
21
|
Mok T, Yang JJ and Lam KC: Treating
patients with EGFR-sensitizing mutations: first line or second line
- is there a difference? J Clin Oncol. 31:1081–1088. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shaw AT, Yeap BY, Solomon BJ, et al:
Effect of crizotinib on overall survival in patients with advanced
non-small-cell lung cancer harbouring ALK gene rearrangement: a
retrospective analysis. Lancet Oncol. 12:1004–1012. 2011.
View Article : Google Scholar : PubMed/NCBI
|
